800-TEMPLE-MED Schedule Appointment

Dr. Leah Croll Offers Insight to NBC10 about Leqembi, Approved by the FDA for the Treatment of Alzheimer’s Disease

View All News

Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, offered insight to NBC10 about Leqembi, which has been granted full approval by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease. The drug is indicated for those with mild cognitive impairment or the mild dementia stage of Alzheimer’s.